| Preliminary Scientific Program - Friday, September 15th, 2006 |
| |
|
Postponed indefinitely - Adiado para data não definida
|
|
INFERTILITY & ART - Hall A |
|
Friday, September 15, 2006 |
|
08 :30-10:00 |
Stem Cells & PGD |
|
|
Capsule: Stem cells are emerging as a future tool for therapy: what are today’s options? |
|
|
Chairpersons: L. Gianaroli, Italy, Y. Verlinsky, USA |
|
08:30-09:00
|
Stem cell therapeutic potential: is the future here?
Y. Verlinsky, USA |
|
09:00-09:30
|
The future of PGD
TBA |
|
09:30-10:00
|
Human embryonic stem cell lines with genetic disorders: what can be learned?
Y. Verlinsky, USA |
|
|
|
|
10:30-12:30 |
When Should We Proceed to IVF? |
|
|
Capsule: Practical issues regarding infertility treatment before and during IVF are not always clear |
|
|
Chairpersons: N. Gleicher, USA, Z. Ben-Rafael, Israel
Discussants: P. Serafini, S. Daya, C. Chillik, S. L. Tan |
|
|
Questions:
Should we always combine hCG with CC?
When should we use aromatase inhibitors?
Gonadotropin - how to start? Low dose or regular dose?
Is IUI mandatory before IVF?
Natural versus stimulated cycle for IUI?
Unexplained infertility, should IVF be the first or last treatment option?
What should be the first-line treatment in PCOS patients, OI with CC, FSH, IVF or IVM?
What is the best way to prevent multiple pregnancies? |
|
13:30–15:30 |
|
|
|
Capsule: The most common endocrinopathy remains an enigma in many aspects |
|
|
Chairpersons: Z. Shoham, Israel, C. Battaglia, Italy |
|
13:30-14:00
|
Polycystic ovarian syndrome: does it exist?
L. V. Machado, Brazil |
|
14:00-14:30
|
Resistance to CC in PCOS patients - how to proceed?
L. Devoto, Chile |
|
14:30-15:00
|
Ovarian drilling or ovulation induction for PCOS?
A. R. Genazzani, Italy |
|
15:00-15:30
|
Which is the best form of ovulation induction: recombinant or urinary gonadotrophins?
C. Petta, Brazil |
| 16:00–17:30 |
Minimal Workup before Infertility Treatment |
|
Capsule: Do we need all the preliminary tests? |
|
Chairpersons: S. L. Tan, Canada, E. Porcu, Italy |
|
16:00-16:30
|
No more need for hysterosalpingogram to diagnose uterine anomalies: we now have 3D ultrasound
I. Timor-Tritsch, USA |
|
16:30-17:00
|
Sophisticated sperm analysis - is it ever required?
P. Patrizio, USA |
|
17:00-17:30
|
Diagnostic laparoscopy – is it ever indicated before IVF?
A. Lewin, Israel |
|
|
|
| 17:30-19:00 |
Hot Controversies in Male Factor infertility |
|
17:30-17:45
|
Comparison of the Rreproductive Pperformance of Ttesticular Sperm with Ejaculated Sperm From Severe Oligospermia
M. Badalotti, Brazil |
|
17:45-18:00
|
Binding Capability of Glycodelin on Human Sperm Surface
G. Keck, Germany |
|
18:00-18:15
|
Top Qality Embryo as a Marker of Success in Male Infertility: Value of Sperm Origin
M. Bibancos, Brazil |
|
18:15-18:30
|
ICSI Outcome Using Frozen Oocytes and Three Different Sperm Sources
A. Arent, Brazil |
|
18:30-18:45
|
Chromosomal Profiles of 1000 Infertile Males with Non-Obstructive Sperm Disorders
M. Ajina, Tunisia |
|
18:45-19:00
|
GnRH agonist long protocol vs short protocol In women 40 years or more
undergoing ICSI : A multicenter study
W. El-Deeb, Egypt |
|
ENDOSCOPY/ MENOPAUSE, FAMILY PLANNING & ONCOLOGY - Hall B |
|
Friday, September 15, 2006 |
|
08:30-10:00 |
Sexual Dysfunction |
|
|
Capsule: Is there a simple agreed choice for treatment? |
|
|
Chairpersons: I. C. Barbosa, Brazil, E.M. Coutinho, Brazil, G. Fucs, Brazil |
|
08:30-09:00
|
Treatment of sexual dysfunction in women using testosterone
E. M. Coutinho, Brazil |
|
09:00-09:30
|
Psychological aspects of sexual dysfunction in women
M. Costa, Brazil |
|
09:30-10:00
|
How women are affected by erectile dysfunction in their partner
P. G. Lopes, Brazil |
|
|
|
|
10:30-12:30 |
Endometriosis |
|
|
Capsule: Can we choose from the many therapeutic options available for this poorly understood condition? |
|
|
Chairpersons: B. Johansson, Sweden, F. Nezhat, USA |
|
10:30-11:00
|
Potential causes of infertility in endometriosis patients
M. Abrao, Brazil |
|
11:00-11:30
|
What constitutes a centre of excellence for endometriosis treatment?
L. Hummelshoj, UK |
|
11:30-12:00
|
Role of laparoscopic treatment of endometriosis in patients with failed IVF
C. Nezhat, USA |
|
12:00-12:30
|
Current Treatment of Deep Endometriosis
M. Abrao, Brazil |
|
13:30-15:30
|
Limitations of Laparoscopy
(Session supported by unresticted grant by Stroz) |
|
|
Capsule: Indications for laparoscopy are expanding, but can it be performed by all? |
|
|
Chairpersons: P. Barrozo, Brazil, Z. Ben Rafael, Israel, C. Nezhat, USA |
|
13:30-14:00
|
Robots and simulators - do they have a role in endoscopic surgery?
C. Nezhat, USA |
|
14:00-14:30
|
The pros and cons of Laparoscopic myomectomy
L. R. Glazerman, USA |
|
14:30-15:00
|
Laparoscopy during pregnancy including cerclage
F. Nezhat, USA |
|
15:00-15:30
|
Management options for uterine fibroids?
L. R. Glazerman, USA |
|
16:00-17:30
|
Laparoscopy – Hysterectomy and Complications
(Session supported by unresticted grant by Stroz) |
|
|
Capsule: Laparoscopy is a potent operative tool, but the debate over safety and indications is still ongoing |
|
|
Chairpersons: C. Nezhat, USA, Z. Hagai, Israel, R. Moore, USA |
|
16:00-16:30
|
LAVH – a procedure whose time has come and gone?
L. R. Glazerman, USA |
|
16:30-17:00
|
Laparoscopic access: what about safety?
C. Nezhat, USA |
|
17:00-17:30
|
Laparoscopic supracervical hysterectomy: is leaving the cervix a problem?
L. R. Glazerman, USA |
|
|
|
| 17:30-18:30 |
Hot Controversies in Gynecology |
|
17:30-17:45
|
Different Treatment Options for Dysfunctional Uterine Bleedings.
G. Grazziotin, Brazil |
|
17:45-18:00
|
Acceptability of Levonorgestrel-Releasing Intrauterine System Inserted Post Surgical Abortion in Chinese Women
D. Zhang, China |
|
18:00-18:15
|
Ovarian Drilling: Results of a Study in a Human Reproduction Service
A. Botto, Brazil |
|
18:15-18:30
|
Tumoral Power Doppler Analysis in Patients with Endometrial Carcinoma
E. C. Blanco , Brazil |
|
|
|
|
|
|
FETO-MATERNAL MEDICINE - Hall C |
|
Friday, September 15, 2006 |
|
08:30-10:00 |
Prenatal Diagnosis and Treatment |
|
|
Capsule: Do increased diagnostic capabilities create more concern? |
|
|
Chairpersons: D. Farine, Canada, I. Timor-Tritsch, USA, S.C. Cha, Brazil |
|
08:30-09:00
|
Down’s syndrome screening with nuchal translucency and nasal bone versus maternal serum markers
I. Timor- Tritsch, USA |
|
09:00-09:30
|
What can biochemical testing add to nuchal translucency?
M. Sinosich, Australia |
|
09:30-10:00
|
Increased nuchal translucency with normal karyotype: Should we ignore it?
Y. Ville, France |
|
|
|
|
10:30-12:30 |
Hot Controversies over Delivery Practice |
|
|
Capsule: Many questions on the risks of delivery remain unanswered |
|
|
Chairpersons: G. C. di Renzo, Italy, S. T. Chasen, USA, H. Petersen, Brazil |
|
10:30-11:00
|
Oral misoprostol for induction of labor
A. Grunebaum, USA |
|
11:00-11:30
|
STAN monitor, pulse oximetry and Cervicometry - “in” or “out”?
D. Farine, Canada |
|
11:30-12:00
|
MgSO4 should it be used for prevention or only for therapeutic?
G. C. di Renzo, Italy |
|
12:00-12:30
|
Identifying vasa previa
S. C. Cha, Brazil |
|
13:30–15:30
|
Workshop: Intrapartum Surveillance - Speakers and Audience
Interaction |
|
|
Capsule: Is it possible to minimize the risk of intrapartum asphyxia? |
|
|
Chairpersons and discussants: J. Gardosi, UK, S. Arulkumaran, UK |
|
|
Questions:
How do we assess 'fetal reserve'?
What is the evidence for intermittent versus continuous monitoring?
How do we assess acid base status?
What are the new monitoring technologies?
Medico-legal implications |
|
|
|
| 15:30–16:00 |
Coffee Break |
|
16:00-17:30 |
Thrombophilia |
|
|
Capsule: Can screening and treatment of Thrombophilia prevent complications? |
|
|
Chairpersons: S. Arulkumaran. UK, L. S. Voto, Argentina, A. C. Lopes, Brazil |
|
16:00-16:40
|
Thrombophilia assessment: What should guidelines look like?
The value of LMWH treatment in Ob/Gyn
D. Blickstein, Israel |
|
16:40-17:05
|
How to deliver a patient on anticoagulants
S. T. Chasen, USA |
|
17:05-17:30
|
How Thrombophilia influences the perinatal outcome"
L. S. Voto, Argentina |
|
|
|
| 17:30-19:00 |
Hot Controversies in Perinatology |
|
17:30-17:45
|
First Trimester Mesurements of Nuchal Translucency, Ductus Venosus and Fetal Nasal Bones and Aneuploidy in Selected Population.
A. C. Vieira Lopes, Brazil |
|
17:45-18:00
|
Primary Repair of Perineal Tears. Thirtee Nine Months Follow Up on 23 Women.
Y. Edden, Israel |
|
18:00-18:15
|
Prophylactic of Immunological Dysfunctions During Pregnancy
M. Pasman, Russia |
|
18:15-18:30
|
Role of Hydrostatic Balloon Catheter in the Management of Major Obstetric haemorrhage
A. Krishna, UK |
|
18:30-18:45
|
Huntington’s Disease (HD)-Free Pregnancy Following Frozen-Thawed Transfer (FET)
P. Serafini, Brazil |
|
18:45-19:00
|
The Controversies in Intrahepatic Cholestasis of Pregnancy
P. Kascak, Slovak Republic | |
|
|
Home 
